High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites (Q41960712)

14 October 2017

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites (English)

1 reference

14 October 2017

9

1 reference

14 October 2017

W Kraan

1

1 reference

14 October 2017

H M Horlings

2

1 reference

14 October 2017

M van Keimpema

3

1 reference

14 October 2017

E J M Schilder-Tol

4

1 reference

14 October 2017

M E C M Oud

5

1 reference

14 October 2017

C Scheepstra

6

1 reference

14 October 2017

P M Kluin

7

1 reference

14 October 2017

M J Kersten

8

1 reference

14 October 2017

S T Pals

10

1 reference

14 October 2017

6 September 2013

1 reference

14 October 2017

1 reference

14 October 2017

3

1 reference

14 October 2017

e139

1 reference

Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Oncogenically active MYD88 mutations in human lymphoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Frequent inactivation of A20 in B-cell lymphomas

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Lymphoma dissemination: the other face of lymphocyte homing

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

The biology of human lymphoid malignancies revealed by gene expression profiling.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3789201

A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

5 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBCJ.2013.28

Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group

21 January 2018

1 reference

12 December 2020

Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics

1 reference

12 December 2020

Testicular lymphoma is associated with a high incidence of extranodal recurrence

1 reference

12 December 2020

Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma.

1 reference

12 December 2020

Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites

1 reference

12 December 2020

Identifiers

DOI

10.1038/BCJ.2013.28

1 reference

Dimensions Publication ID

14 October 2017

1028068066

0 references

Fatcat ID

release_3pybgadumjapnmuupju4w6bbee

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3pybgadumjapnmuupju4w6bbee

24 November 2022

mapped directly with Wikidata item

1 reference

14 October 2017

PubMed publication ID

24013661

1 reference